JENNIFER EBERTSHAUSER: Open Payments
NPI 1316251903 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 18 payments from 11 companies in 2025. Trend: 2023 $290 · 2024 $467 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| ABBVIE INC. | 2 | $38 |
| Abbott Laboratories | 2 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| PhotoniCare Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: BREZTRI, AIRSUPRA, Veozah, CAPLYTA, UBRELVY, NURTEC ODT, Wegovy, OtoSight Middle Ear Scope.
Industry payments across AZ — which companies pay providers there.
